Ritedose, South Carolina’s Leading Pharmaceutical Manufacturer, Buys 105 Acres of Land for Major Expansion.
50-percent growth in pharmaceutical manufacturing and sales spurs expansion, job creation
Ritedose Releases Two New Single-Dose Syringe Products for Hospital Pharmacies: <em>Phenylephrine Hydrochloride Injection 0.8 mg/10 mL (80 mcg/mL) and Phenylephrine Hydrochloride Injection 1 mg/10 mL (100 mcg/mL)</em>
COLUMBIA, S.C. (May 21, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, launched two new unit dose syringe products, Phenylephrine Hydrochloride Injection 0.8 mg/10 mL (80 mcg/mL) and Phenylephrine Hydrochloride Injection 1 mg/10 mL (100 mcg/mL). These are part of a six-month, 12-product rollout from Ritedose for
Ritedose Brings New Unit Dose Syringe Product to the Market: <em>Succinylcholine Chloride Injection 100 mg/5 mL (20 mg/mL)</em>
COLUMBIA, S.C. (May 14, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Succinylcholine Chloride Injection 100 mg/5 mL (20 mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the country. Ritedose is a
Recent Comments